| scholarly article | Q13442814 |
| P2093 | author name string | D E Gomez | |
| P Argibay | |||
| M L Pellegrini | |||
| P2860 | cites work | Translating the Histone Code | Q22065840 |
| Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer | Q74111483 | ||
| Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma | Q74216156 | ||
| Mechanisms of genomic imprinting | Q74308070 | ||
| Expression of p57/Kip2 protein in hepatocellular carcinoma | Q74562732 | ||
| Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability | Q77534962 | ||
| Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2 | Q78532732 | ||
| Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors | Q78801621 | ||
| Loss of p57KIP2 is associated with colorectal carcinogenesis | Q79287385 | ||
| Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas | Q79719664 | ||
| Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer | Q79836725 | ||
| Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population | Q81251144 | ||
| Genetic alterations in colorectal cancers with demethylation of insulin-like growth factor II | Q81625047 | ||
| Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2 | Q82353010 | ||
| Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer | Q83128045 | ||
| Parental imprinting of the mouse H19 gene | Q22122365 | ||
| Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria | Q24317481 | ||
| A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 | ||
| Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15 | Q24568014 | ||
| The product of the H19 gene may function as an RNA | Q24599284 | ||
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
| CDK inhibitors: positive and negative regulators of G1-phase progression | Q27860983 | ||
| Genomic insulators: connecting properties to mechanism | Q28176763 | ||
| Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues | Q28206748 | ||
| Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase | Q28213355 | ||
| Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors | Q28215348 | ||
| Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay | Q28279940 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| Cloning, mapping and RNA analysis of the human methionine synthase gene | Q28299625 | ||
| Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution | Q28300442 | ||
| Human methionine synthase. cDNA cloning, gene localization, and expression | Q28302419 | ||
| Genomic imprinting: parental influence on the genome | Q29616227 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| DNA methylation in health and disease | Q30659938 | ||
| Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer. | Q33325473 | ||
| Genetic testing in hereditary colorectal cancer: indications and procedures | Q33731657 | ||
| Cytosine methylation and human cancer | Q33845225 | ||
| Epidemiologic studies of folate and colorectal neoplasia: a review | Q33960655 | ||
| Insulin-like growth factor physiology and neoplasia | Q34030646 | ||
| Uniparental paternal disomy in a genetic cancer-predisposing syndrome | Q34535432 | ||
| Hereditary nonpolyposis colorectal cancer (Lynch syndromes I & II). Genetics, pathology, natural history, and cancer control, Part I. | Q34564939 | ||
| Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer | Q34620502 | ||
| Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. | Q34680586 | ||
| Epigenetics: a historical overview | Q34713017 | ||
| DNA methylation in cancer: too much, but also too little | Q34770545 | ||
| Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. | Q53404629 | ||
| [Genetic mechanisms in the hereditary predisposition to colorectal cancer] | Q54465971 | ||
| Methionine Synthase Reductase Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer | Q55036516 | ||
| Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
| Inheritance of a Cancer-AssociatedMLH1Germ-Line Epimutation | Q56588356 | ||
| MLH1 Germline Epimutations as a Factor in Hereditary Nonpolyposis Colorectal Cancer | Q56589268 | ||
| Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour | Q57976817 | ||
| Tumors with microsatellite instability: many mutations, targets and paradoxes | Q57977998 | ||
| Reduced genomic 5-methylcytosine content in human colonic neoplasia | Q68266400 | ||
| A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer | Q71733953 | ||
| Relaxation of imprinting of the insulin-like growth factor II gene in colorectal cancer | Q71768453 | ||
| Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor | Q71909564 | ||
| Parental genomic imprinting of the human IGF2 gene | Q72222239 | ||
| Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history | Q72657539 | ||
| Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site | Q73006826 | ||
| A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk | Q73022888 | ||
| Hereditary colorectal cancer | Q73088287 | ||
| Loss of IGF2 imprinting: a potential marker of colorectal cancer risk | Q73128690 | ||
| Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells | Q73430510 | ||
| Microsatellite instability | Q73683104 | ||
| Expression of second class of KIP protein p57KIP2 in human colorectal carcinoma | Q74027818 | ||
| The genetics of colorectal cancer | Q34920581 | ||
| The role of insulin-like growth factor 2 and its receptors in human tumors | Q35073688 | ||
| Relevance of DNA methylation in the management of cancer | Q35146155 | ||
| A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability | Q35594520 | ||
| Epigenetic changes in colorectal cancer. | Q35682096 | ||
| 5,10-methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer | Q35967127 | ||
| Epigenetic regulation by histone methylation and histone variants | Q36022792 | ||
| Causes and consequences of DNA hypomethylation in human cancer | Q36164751 | ||
| DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer | Q36613849 | ||
| Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. | Q36820044 | ||
| Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer | Q36835706 | ||
| Structural and Regulatory Aspects of the Human Genes Encoding IGF-I and -II | Q36901830 | ||
| Folate and colorectal cancer prevention. | Q37081089 | ||
| Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene | Q37207227 | ||
| Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis | Q37268177 | ||
| Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse | Q38291049 | ||
| The role of migrant population in studies of selected cancer sites: A review | Q39995548 | ||
| MTHFR C677T has differential influence on risk of MSI and MSS colorectal cancer | Q40235187 | ||
| Parental imprinting of autosomal mammalian genes | Q40672445 | ||
| DNA methylation and genomic imprinting in mammals. | Q40868394 | ||
| BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. | Q40907031 | ||
| Cancer patterns of four ethnic groups in Hawaii. | Q41610675 | ||
| Initial characterization of the four promoters of the human insulin-like growth factor II gene | Q41662956 | ||
| Methylenetetrahydrofolate reductase, diet, and risk of colon cancer | Q41675825 | ||
| A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma | Q43668835 | ||
| Examination of IGF2 and H19 loss of imprinting in bladder cancer. | Q44048722 | ||
| Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. | Q44087024 | ||
| Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. | Q44191190 | ||
| The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase | Q44693825 | ||
| Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. | Q44825196 | ||
| The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. | Q44908747 | ||
| Inactivation of imprinted genes induced by cellular stress and tumorigenesis | Q45234566 | ||
| A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor | Q46205474 | ||
| Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer | Q46801208 | ||
| MTHFR polymorphisms as prognostic factors in sporadic colorectal cancer. | Q46958737 | ||
| Germline epimutation of MLH1 in individuals with multiple cancers | Q47817335 | ||
| Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation | Q47900106 | ||
| Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors | Q48063609 | ||
| Altered specificity of IGF2 promoter imprinting during fetal development and onset of Wilms tumour | Q48071387 | ||
| Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. | Q48096674 | ||
| Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. | Q49057362 | ||
| Imprinting mechanisms. | Q52184196 | ||
| Lack of imprinting of three human cyclin-dependent kinase inhibitor genes. | Q52196115 | ||
| Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability. | Q52539921 | ||
| Relaxation of imprinted genes in human cancer. | Q52545355 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 241-250 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
| P1476 | title | Dietary factors, genetic and epigenetic influences in colorectal cancer | |
| P478 | volume | 1 |
| Q35544952 | DNA-methyltransferase 3B 39179 G > T polymorphism and risk of sporadic colorectal cancer in a subset of Iranian population. | cites work | P2860 |
Search more.